Peripheral Vascular Devices Market Insights

According to a new report from Intel Market Research, the global Peripheral Vascular Devices market was valued at USD 8.45 billion in 2025 and is projected to reach USD 16.38 billion by 2034, growing at a robust CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of diabetes and obesity, an aging population, and rapid technological innovation in minimally invasive endovascular therapies.

Peripheral vascular devices are medical instruments designed to diagnose, treat, and manage conditions affecting blood vessels outside the heart and brain, particularly the peripheral arteries and veins. These devices play a critical role in addressing peripheral artery disease (PAD), chronic venous insufficiency, and other vascular disorders by restoring blood flow, reducing blockages, and preventing complications such as limb ischemia or stroke. Key product categories include angioplasty balloons, stents, atherectomy devices, chronic total occlusion (CTO) crossing devices, embolic protection systems, guidewires, catheters, vascular grafts, and inferior vena cava (IVC) filters. Advances in minimally invasive technologies have significantly enhanced efficacy and safety while reducing patient recovery times.

Download FREE Sample Report:
Peripheral Vascular Devices Market - View in Detailed Research Report

Key Statistics:

2025 Market Size

USD 8.45 billion

2034 Projected Market Size

USD 16.38 billion

CAGR (2025–2034)

7.6 %

Largest Market in 2025

North America

Key Takeaways: Peripheral Vascular Devices Market

• The market expands from USD 8.45 billion in 2025 to an estimated USD 16.38 billion by 2034, delivering a compound annual growth rate of roughly 7.6 %.

• North America accounts for just over 40 % of global sales in the base year, keeping its lead despite accelerating uptake in Europe and Asia‑Pacific.

• Drug‑eluting stents and atherectomy platforms together generate about 55 % of total revenue, underscoring clinicians’ shift toward less invasive therapies.

• The diabetes burden exceeds 540 million adults worldwide, meaning patients with diabetes represent upwards of 60 % of peripheral artery disease interventions.

• Laser atherectomy and ultrasound‑assisted plaque modification register double‑digit growth since 2022, emerging as the fastest‑expanding product segment.

Analyst Note

Demand remains anchored to demographic trends; an aging population coupled with rising metabolic disease prevalence pushes hospitals toward endovascular solutions that shorten stays and lower complication risk. While North America continues to dominate volume, Europe’s outcome‑based reimbursement schemes and Asia‑Pacific’s expanding outpatient infrastructure create parallel avenues for growth. Companies that bundle advanced imaging with therapeutic delivery or that can demonstrate clear cost offsets through reduced readmissions stand to capture premium contracts across regions.

What is Peripheral Vascular Devices?

Peripheral vascular devices encompass a broad portfolio of catheter‑based systems and implantable solutions that enable clinicians to perform percutaneous interventions across the peripheral circulatory network. From balloon angioplasty that dilates narrowed arterial segments to drug‑eluting stents that inhibit restenosis, these technologies empower physicians to treat complex atherosclerotic lesions with reduced procedural trauma. Emerging platforms such as bio‑resorbable scaffolds, laser atherectomy, and IoT‑enabled guidewires further expand therapeutic options, aligning with value‑based care models that prioritize rapid recovery and lower overall cost of care.

This report provides a deep insight into the global Peripheral Vascular Devices market covering all essential aspects-from macro‑level market size and growth trends to micro‑level competitive landscape, technology roadmaps, and strategic recommendations for stakeholders.

Key Market Drivers

1. Demographic Shifts and Disease Prevalence
The aging global population-projected to reach one in six people over 60 by 2030 (World Health Organization)-and the escalating burden of diabetes (over 537 million adults in 2021, expected 783 million by 2045, International Diabetes Federation) create a sizable patient pool for peripheral vascular interventions. PAD prevalence rises to more than 12 % among those aged 65+, fueling demand for endovascular solutions.

2. Technological Innovation
Breakthroughs in drug‑eluting stents, bio‑resorbable scaffolds, atherectomy platforms, and imaging‑guided navigation have markedly improved clinical outcomes, encouraging physicians to replace surgical bypass with percutaneous therapies. Integration of digital sensors and remote monitoring further enhances procedural precision and post‑procedure management.

➤ In 2023, the global market size exceeded USD 6.5 billion, reflecting a compound annual growth rate of approximately 8 % since 2018.

Hospital consolidation and the rise of specialized vascular centers streamline procurement, enabling bulk purchasing and faster diffusion of advanced therapies across regions.

Market Challenges

Regulatory Hurdles
Stringent pre‑market approval requirements across the U.S., EU, and Asia‑Pacific extend product launch timelines and increase development costs. Diverse clinical evidence standards demand substantial investment in multi‑regional trials.

Reimbursement Complexity
Variations in coverage policies, especially for novel drug‑coated balloons, lead to inconsistent reimbursement rates. Delayed payments can dampen adoption in cost‑sensitive health systems.

Supply Chain Vulnerabilities
Global semiconductor shortages and logistics bottlenecks affect manufacturing of sensor‑integrated catheters, creating intermittent inventory gaps that interrupt treatment continuity.

Market Restraints

High Capital Investment
Acquisition of high‑resolution imaging suites and robotic assistance platforms demands significant upfront capital, limiting uptake in smaller hospitals and emerging economies.

Clinical Training Requirements
Advanced peripheral interventions require specialized operator expertise. Ongoing education programs increase operational costs and can slow uptake where training infrastructure is limited.

Perceived procedural complications such as distal embolization also restrain some clinicians from adopting device‑based therapies.

Emerging Opportunities

Minimally Invasive Therapies
Laser atherectomy and ultrasound‑assisted plaque modification offer potential to treat heavily calcified lesions with minimal tissue trauma, positioning these technologies for rapid market capture.

Digital Integration and Remote Monitoring
IoT sensors embedded in guidewires enable real‑time hemodynamic feedback, supporting personalized therapy adjustments and aligning with outcome‑based reimbursement frameworks.

Expanding middle‑class populations in Latin America and Southeast Asia are increasing demand for outpatient vascular procedures, presenting clear growth avenues for cost‑effective product lines.

Regional Market Insights

North America remains the largest market, driven by an aging baby‑boom cohort, mature reimbursement mechanisms, and a favorable regulatory environment. Medicare and private insurers reward minimally invasive procedures, prompting hospitals to upgrade endovascular suites. The FDA’s evolving guidance on device safety creates a predictable pathway for innovators, encouraging large‑scale clinical trials and accelerated product launches.

Europe exhibits sophisticated adoption with CE‑marking processes and outcome‑based reimbursement schemes that prioritize technologies reducing limb‑loss incidence. National health services in Germany, France, and the UK negotiate centrally, leveraging volume to secure favorable pricing while emphasizing robust clinical evidence.

Asia‑Pacific shows rapid demand growth tempered by heterogeneous regulatory pathways. Japan and South Korea maintain rigorous approvals, whereas China streamlines its NMPA processes to attract foreign investment. Urban lifestyle shifts increase PAD prevalence, driving hospital capacity expansion and partnerships between local manufacturers and multinational OEMs.

South America faces budget‑constrained public sectors that favor durable, cost‑effective devices. Brazil and Argentina dominate procurement volumes, but import reliance introduces currency volatility. Private clinics in metropolitan hubs are more willing to experiment with innovative catheters and drug‑coated technologies.

Middle East & Africa displays appetite for high‑end solutions in affluent private markets, yet limited reimbursement frameworks and fragmented supply chains pose challenges. Investment in tertiary care centers has spurred demand for cutting‑edge imaging and atherectomy devices; regional training academies and bundled service packages help overcome logistical hurdles.

Market Segmentation

By Type

• Stents (bare‑metal and drug‑eluting)

• Atherectomy devices

• Angioplasty balloons

• Embolic protection systems

• Drug‑coated peripheral devices

By Application

• Peripheral arterial disease (PAD) treatment

• Critical limb ischemia interventions

• Vascular access creation for dialysis

• Venous insufficiency management

• Other niche therapeutic uses

By End User

• Acute care hospitals

• Ambulatory surgical centers (ASCs)

• Specialty vascular clinics

By Region

• North America

• Europe

• Asia‑Pacific

• Latin America

• Middle East & Africa

Segment Analysis:

Competitive Landscape

The Peripheral Vascular Devices market is dominated by a handful of large multinational corporations that leverage extensive product portfolios, global distribution networks, and robust R&D pipelines.

Key Industry Players

• Medtronic

• Abbott Vascular

• Boston Scientific

• Terumo Corporation

• Gore Medical

• Cook Medical

• Cordis (Johnson & Johnson)

• AngioDynamics

• Merit Medical Systems

• Becton Dickinson (BD)

• Philips Healthcare

• C. R. Bard

• Cardinal Health

• Vascular Solutions, Inc.

Beyond the tier‑one giants, specialized firms such as Cook Medical, Cordis, AngioDynamics, and Merit Medical drive product differentiation and regional penetration through precision‑engineered delivery systems, niche therapeutic tools, and strategic collaborations with academic centers.

Report Deliverables

• Global and regional market forecasts from 2026 to 2034

• Strategic insights into pipeline developments, clinical trials, and regulatory approvals

• Market share analysis and SWOT assessments for key players

• Pricing trends and reimbursement dynamics across major jurisdictions

• Comprehensive segmentation by type, application, end‑user, and geography

Get Full Report Here:
Peripheral Vascular Devices Market - View Detailed Research Report

Frequently Asked Questions

What is the current market size of Peripheral Vascular Devices Market?

Global Peripheral Vascular Devices Market was valued at USD 8.45 billion in 2025 and is expected to reach USD 16.38 billion by 2034.

Which key companies operate in Peripheral Vascular Devices Market?

Key players include Medtronic, Abbott Vascular, Boston Scientific, Terumo, Gore Medical, Cook Medical, Cordis (Johnson & Johnson), AngioDynamics, Merit Medical, Becton Dickinson (BD), Philips Healthcare, C. R. Bard, Cardinal Health, Vascular Solutions, Inc.

What are the key growth drivers?

Key growth drivers include the rising global prevalence of diabetes and obesity, an aging population, technological innovations such as drug‑eluting and bio‑resorbable devices, and strategic collaborations among leading manufacturers.

Which region dominates the market?

North America currently holds the largest market share, while Asia‑Pacific is the fastest‑growing region.

What are the emerging trends?

Emerging trends include minimally invasive laser atherectomy, ultrasound‑assisted plaque modification, integration of IoT sensors into guidewires for real‑time monitoring, and digital platforms that support remote therapy adjustments.

About Intel Market Research

Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:

• Real-time competitive benchmarking

• Global clinical trial pipeline monitoring

• Country-specific regulatory and pricing analysis

• Over 500+ healthcare reports annually

Trusted by Fortune 500 companies, our insights empower decision‑makers to drive innovation with confidence.

🌐 Website: https://www.intelmarketresearch.com
📞 Asia-Pacific: +91 9169164321
🔗 LinkedIn: Follow Us